Literature DB >> 6414006

The effect of chronic treatment with antidepressant drugs on salbutamol-induced hypoactivity in rats.

E Przegaliński, L Baran, J Siwanowicz.   

Abstract

Several lines of evidence (binding studies, reduced responsiveness of brain adenylate cyclase to noradrenergic stimulation, electrophysiological data) indicate that chronic treatment with antidepressant drugs induces subsensitivity of central beta-adrenergic receptors. We studied the effect of acute (single dose) and chronic (14 days, twice daily) treatment with imipramine, desmethylimipramine, amitriptyline, fluvoxamine and citalopram (10 mg/kg, orally) on salbutamol-induced suppression of exploratory activity in rats. This effect of salbutamol was antagonized by chronic, but not acute treatment with antidepressants. Chronic treatment with antidepressants as a rule did not significantly affect exploratory activity. Our results may be regarded as functional evidence at the behavioural level for the subsensitivity of beta-adrenergic receptors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6414006     DOI: 10.1007/BF00432120

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  39 in total

1.  Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. IV. Influence of haloperidol (R 1625) and of chlorpromazine on the behaviour of rats in an unfamiliar "open field" situation.

Authors:  P A JANSSEN; A H JAGENEAU; K H SCHELLEKENS
Journal:  Psychopharmacologia       Date:  1960-09-13

2.  Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain.

Authors:  J Vetulani; F Sulser
Journal:  Nature       Date:  1975-10-09       Impact factor: 49.962

3.  Development of beta-adrenergic receptor subsensitivity by antidepressants.

Authors:  S P Banerjee; L S Kung; S J Riggi; S K Chanda
Journal:  Nature       Date:  1977-08-04       Impact factor: 49.962

4.  Experimental and clinical evidence of the antidepressant effect of a beta-adrenergic stimulant.

Authors:  P Simon; Y Lecrubier; R Jouvent; A J Puech; J F Allilaire; D Widlöcher
Journal:  Psychol Med       Date:  1978-05       Impact factor: 7.723

5.  A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine.

Authors:  D T Wong; J S Horng; F P Bymaster; K L Hauser; B B Molloy
Journal:  Life Sci       Date:  1974-08-01       Impact factor: 5.037

6.  Metabolic studies of Salbutanol-3H: a new bronchodilator, in rat, rabbit, dog and man.

Authors:  L E Martin; J C Hobson; J A Page; C Harrison
Journal:  Eur J Pharmacol       Date:  1971-04       Impact factor: 4.432

7.  Functional evidence for subsensitivity of noradrenergic alpha 2 receptors after chronic desipramine treatment.

Authors:  C Spyraki; H C Fibiger
Journal:  Life Sci       Date:  1980-11-17       Impact factor: 5.037

8.  A beta adrenergic stimulant (salbutamol) versus clomipramine in depression: a controlled study.

Authors:  Y Lecrubier; A J Puech; R Jouvent; P Simon; D Widlocher
Journal:  Br J Psychiatry       Date:  1980-04       Impact factor: 9.319

9.  The noradrenaline receptor coupled adenylate cyclase system in brain. Lack of modification by changes in the availability of serotonin.

Authors:  R Mishra; N J Leith; L Steranka; F Sulser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

10.  alpha 2-Adrenoreceptors in rat brain are decreased after long-term tricyclic antidepressant drug treatment.

Authors:  C B Smith; J A Garcia-Sevilla; P J Hollingsworth
Journal:  Brain Res       Date:  1981-04-06       Impact factor: 3.252

View more
  9 in total

1.  Differential effects of chronic antidepressants in behavioural tests of beta-adrenergic and GABAB receptor function.

Authors:  D J McManus; A J Greenshaw
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Behavioral evidence for beta-adrenoceptor subsensitivity after subacute antidepressant/alpha 2-adrenoceptor antagonist treatment.

Authors:  J M Goldstein; L C Knobloch-Litwin; J B Malick
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

3.  Tolerance to or facilitation of pharmacological effects induced by chronic treatment with the beta-adrenergic stimulant clenbuterol.

Authors:  H Francès; B Diquet; P Goldschmidt; P Simon
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

4.  Repeated treatment with antidepressant drugs increases the behavioural response to apomorphine.

Authors:  J Maj; Z Rogóz; G Skuza; H Sowińska
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

5.  Chronic treatment with the potential antidepressant drug rolipram: the effect on the behavioural responses to adrenergic and dopaminergic receptor agonists with some biochemical correlates.

Authors:  E Przegaliński; L Baran; J Siwanowicz; G Nowak; L Antkiewicz-Michaluk; J Vetulani
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

6.  Adaptive and differential changes on beta- and alpha 2-adrenoreceptors mediated hyperthermia after chronic treatment with antidepressant drugs in the rat kept at high ambient temperature.

Authors:  E Mogilnicka; V Klimek; G Nowak; A Czyrak
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

7.  The effect of chronic administration of amitriptyline on the effects of subsequent electroconvulsive treatment on responsiveness of alpha 1-and beta-adrenoceptors in the rat cortical slices.

Authors:  J Vetulani; I Nalepa
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

8.  Down-regulation of beta-adrenergic and dopaminergic receptors induced by 2-phenylethylamine.

Authors:  P R Paetsch; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1993-06       Impact factor: 5.046

Review 9.  2-Phenylethylamine-induced changes in catecholamine receptor density: implications for antidepressant drug action.

Authors:  P R Paetsch; A J Greenshaw
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.